Drug that blocks histamine or histamine agonists
Antihistamines are drugs that treat hay fever and other allergies. Typically, people take antihistamines as an inexpensive, generic (not patented) drug that can be bought without a prescription and provides relief from nasal congestion, sneezing, or hives caused by pollen, dust mites, or animal allergy with few side effects. Antihistamines are usually for short-term treatment. Chronic allergies increase the risk of health problems which antihistamines might not treat, including asthma, sinusitis, and lower respiratory tract infection. Consultation of a medical professional is recommended for those who intend to take antihistamines for longer-term use.
Although the general public typically uses the word "antihistamine" to describe drugs for treating allergies, physicians and scientists use the term to describe a class of drug that opposes the activity of histamine receptors in the body. In this sense of the word, antihistamines are subclassified according to the histamine receptor that they act upon. The two largest classes of antihistamines are H1-antihistamines and H2-antihistamines.
H1-antihistamines work by binding to histamine H1 receptors in mast cells, smooth muscle, and endothelium in the body as well as in the tuberomammillary nucleus in the brain. Antihistamines that target the histamine H1-receptor are used to treat allergic reactions in the nose (e.g., itching, runny nose, and sneezing). In addition, they may be used to treat insomnia, motion sickness, or vertigo caused by problems with the inner ear. H2-antihistamines bind to histamine H2 receptors in the upper gastrointestinal tract, primarily in the stomach. Antihistamines that target the histamine H2-receptor are used to treat gastric acid conditions (e.g., peptic ulcers and acid reflux). Other antihistamines also target H3 receptors and H4 receptors.
Histamine receptors exhibit constitutive activity, so antihistamines can function as either a neutral receptor antagonist or an inverse agonist at histamine receptors. Only a few currently marketed H1-antihistamines are known to function as antagonists.
Safety at a Glance
High Risk- General Principles
- Start low, go slow: Always begin with a low dose, especially with unfamiliar batches or new substances. Individual se...
- Toxicity: First-generation H1-antihistamines potentially cause adverse effects in multiple body systems. CNS adverse effects of...
- Overdose risk: Limited specific overdose data is available for Antihistamine. In the absence of compound-specifi...
If someone is in crisis, call 911 or Poison Control: 1-800-222-1222
Duration
No duration data available.
Subjective Effects
The effects listed below are based on the Subjective Effect Index (SEI), an open research literature based on anecdotal reports and personal analyses. They should be viewed with a healthy degree of skepticism. These effects will not necessarily occur in a predictable or reliable manner, although higher doses are more liable to induce the full spectrum of effects.
Physical Effects
Physical(4)
- Increased heart rate— A noticeable acceleration of heartbeat that can range from a subtle awareness of one's pulse to a fo...
- Respiratory depression— A dangerous slowing and shallowing of breathing that can progress from barely noticeable reductions ...
- Sedation— A state of deep physical and mental calming that manifests as a progressive desire to remain still, ...
- Seizure— Uncontrolled brain electrical activity causing convulsions and loss of consciousness -- a life-threa...
Cognitive & Perceptual Effects
Cognitive(2)
- Depression— A persistent state of low mood, emotional numbness, hopelessness, and diminished interest or pleasur...
- Wakefulness— An increased ability to stay awake and alert without the desire to sleep. Distinct from stimulation ...
Pharmacology
Most antihistamines act as inverse agonists on histamine receptors, meaning they inhibit the action of histamine by preventing it from binding to them. They may also inhibit the enzymatic activity of histidine decarboxylase which catalyzes the transformation of histidine into histamine.
First-generation antihistamines readily cross the blood–brain barrier (BBB) and occupy H1-receptors located on postsynaptic membranes of histaminergic neurons throughout the central nervous system (CNS). Most of these drugs have antimuscarinic anticholinergic effects, some have alpha-adrenergic blocking effects, and others can inhibit both histamine and 5-HT activity. Second-generation H1-antihistamineshave significantly less affinity for muscarinic cholinergic and alpha-adrenergic receptors and cross the BBB to a minimal degree, penetrate poorly into the CNS, and typically occupy fewer than 20% of CNS H1-receptors.
The promotion of sleep by antihistamines with sedative properties may partially be due to the antagonism of histamine receptors in the ventrolateral preoptic area (VLPO) located in the hypothalamus. When the VLPO is stimulated, it increases the frequency of GABAergic activity within other wake-promoting sites of the brain as an inhibitory process to wakefulness. In contrast, the VLPO is inhibited by histaminergic activity, primarily from the tuberomammillary nucleus (TMN); deactivating the VLPO in order to promote wakefulness (primarily in the transition from sleep to wake).
Interactions
No documented interactions.
History
The first H1 receptor antagonists were discovered in the 1930s and were marketed in the 1940s. Piperoxan was discovered in 1933 and was the first compound with antihistamine effects to be identified. Piperoxan and its analogues were too toxic to be used in humans. Phenbenzamine (Antergan) was the first clinically useful antihistamine and was introduced for medical use in 1942. Subsequently, many other antihistamines were developed and marketed. Diphenhydramine (Benadryl) was synthesized in 1943, tripelennamine (Pyribenzamine) was patented in 1946, and promethazine (Phenergan) was synthesized in 1947 and launched in 1949. By 1950, at least 20 antihistamines had been marketed. Chlorphenamine (Piriton), a less sedating antihistamine, was synthesized in 1951, and hydroxyzine (Atarax, Vistaril), an antihistamine used specifically as a sedative and tranquilizer, was developed in 1956. The first non-sedating antihistamine was terfenadine (Seldane) and was developed in 1973. Subsequently, other non-sedating antihistamines like loratadine (Claritin), cetirizine (Zyrtec), and fexofenadine (Allegra) were developed and introduced.
The introduction of the first-generation antihistamines marked the beginning of medical treatment of nasal allergies. Research into these drugs led to the discovery that they were H1 receptor antagonists and also to the development of H2 receptor antagonists, where H1-antihistamines affected the nose and the H2-antihistamines affected the stomach. This history has led to contemporary research into drugs which are H3 receptor antagonists and which affect the H4 receptor antagonists. Most people who use an H1 receptor antagonist to treat allergies use a second-generation drug.
Harm Reduction
General Principles
- Start low, go slow: Always begin with a low dose, especially with unfamiliar batches or new substances. Individual sensitivity varies enormously.
- Test your substances: Use reagent test kits to verify identity and check for dangerous adulterants. Consider using drug checking services where available.
- Research thoroughly: Understand expected dose ranges, duration, potential interactions, and contraindications before use.
- Never use alone: Have a trusted, sober person present, especially with new substances or higher doses.
- Set and setting: Your mindset and environment profoundly influence the experience. Choose a safe, comfortable environment and ensure you're in a stable psychological state.
Antihistamine-Specific Considerations
As with any psychoactive substance, individual sensitivity to Antihistamine can vary significantly. Start with conservative doses, thoroughly research the compound's specific risk profile, and consider the broader context of your physical and mental health before use.
Toxicity & Safety
First-generation H1-antihistamines potentially cause adverse effects in multiple body systems. CNS adverse effects of antihistamines are due to inverse agonism at CNS H1-receptors, inhibition of neurotransmission in histaminergic neurons, and impairment of alertness, cognition, learning, and memory that is not necessarily associated with sedation, fatigue, or somnolence. After an overdose, some first-generation H1-antihistamines potentially lead to sinus tachycardia, prolongation of the QT interval, ventricular arrhythmias, and torsade de pointes.
In contrast to first-generation H1-antihistamines, second-generation H1-antihistamines are relatively free from antihistaminic adverse CNS effects and from antimuscarinic, antiserotonin, and anti–α-adrenergic effects. Massive overdoses of second-generation H1-antihistamines, such as cetirizine, fexofenadine, and loratadine, have not been causally linked with seizures, coma, respiratory depression, or fatality.
Overdose Information
Limited specific overdose data is available for Antihistamine. In the absence of compound-specific information, general principles apply:
If someone exhibits signs of medical distress after using Antihistamine — difficulty breathing, severe confusion, seizures, chest pain, extremely elevated temperature, or loss of consciousness — treat it as a medical emergency. Call emergency services and be forthcoming about what was consumed. Medical professionals follow confidentiality protocols and their priority is saving lives.
Prevention remains the best approach: use the minimum effective dose, avoid combining with other substances, and always have a sober person present who can recognize signs of distress and call for help.
Tolerance
| Full | Unknown |
| Half | Unknown |
| Zero | Unknown |
Legal Status
The legal status of Antihistamine varies by jurisdiction and is subject to change. This information is provided for educational purposes and may not reflect the most current legislation.
General patterns: Many psychoactive substances are controlled under national and international drug control frameworks, including the United Nations Single Convention on Narcotic Drugs (1961), the Convention on Psychotropic Substances (1971), and country-specific legislation such as the US Controlled Substances Act, UK Misuse of Drugs Act, and EU Framework Decisions.
Research chemicals and analogues: Novel psychoactive substances may be captured by analogue laws (e.g., the US Federal Analogue Act) or blanket bans on substance classes (e.g., the UK Psychoactive Substances Act 2016), even if the specific compound is not individually scheduled.
Important note: Possessing, distributing, or manufacturing controlled substances carries serious legal consequences in most jurisdictions. Legal status is not a reliable indicator of a substance's safety profile — some highly dangerous substances are legal, while some with favorable safety profiles are strictly controlled.
Users are strongly encouraged to research the specific legal status of Antihistamine in their jurisdiction before any involvement with this substance.
Experience Reports (3)
Tips (5)
First-generation antihistamines like diphenhydramine (Benadryl) and doxylamine carry real risks with chronic use. Long-term use has been associated with increased dementia risk in multiple studies. Developing psychological dependence on antihistamines for sleep is common and insidious. If you rely on them nightly, work with your doctor on alternatives. Occasional use is generally fine.
Research potential interactions before combining Antihistamine with other substances. Drug interactions can be unpredictable and dangerous.
If you are taking DXM-containing products, be extremely cautious about antihistamine content. Many cough syrups contain both DXM and antihistamines (chlorpheniramine, doxylamine). At recreational DXM doses, the antihistamine component can reach toxic levels causing seizures, cardiac arrhythmias, and delirium. Always check the label for active ingredients and use DXM-only formulations.
For antihistamines used as anxiolytics (particularly hydroxyzine), finding the right dose makes all the difference. Many people start too high and get knocked out. Start at 12.5mg and titrate up. At 50mg most people will be sedated heavily; at 12.5-25mg the anti-anxiety effects can be present without overwhelming drowsiness. Cut pills to find your threshold.
Keep a usage log for Antihistamine including dose, time, effects, and side effects. This helps you identify patterns and prevent problematic escalation.
Community Discussions (3)
References (2)
- Antihistamine - TripSit Factsheet
TripSit factsheet for Antihistamine
tripsit - Antihistamine - Wikipedia
Wikipedia article on Antihistamine
wikipedia